Correlation of Plasma Copeptin and Vasopressin Concentrations in Hypo-, Iso-, and Hyperosmolar States
Open accessThe DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Abstract
Background: Copeptin, the C-terminal moiety of provasopressin, is cosecreted with vasopressin. Copeptin may be a useful parameter to characterize disorders of water homeostasis and can be readily measured in plasma or serum. However, it is unknown to date how circulating copeptin and vasopressin levels correlate at different plasma osmolalites. Objective: To correlate plasma copeptin with plasma osmolality and vasopressin concentrations in healthy subjects during iso-, hypo-, and hyperosmolar states. Methods: Plasma osmolalities, copeptin, and vasopressin levels were measured in 20 volunteers at baseline, after an oral water load, and during and after iv infusion of 3% saline. Correlation coefficients were determined between plasma osmolalites and copeptin and vasopressin concentrations, as well as between vasopressin and copeptin concentrations. Results: Median plasma osmolalities decreased from 290 mOsm/kg (range, 284–302) at baseline to 281 (273–288) mOsm/kg after water load and rose to 301 (298–307) mOsm/kg after hypertonic saline. Median plasma copeptin concentrations decreased from 3.3 (1.1–36.4) pm at baseline to 2.0 (0.9–10.4) pm after water load and increased to 13.6 (3.7–43.3) pm after hypertonic saline. Vasopressin and copeptin concentrations correlated with plasma osmolality (Spearman's rank correlation coefficient 0.49 and 0.77, respectively). There was a close correlation of vasopressin and copeptin concentrations (Spearman's rank correlation coefficient 0.8). Conclusion: Plasma vasopressin and copeptin correlate strongly over a wide range of osmolalities in healthy individuals. Therefore, the measurement of copeptin, which remains stable for several days, is a useful alternative to vasopressin measurements and will likely facilitate the differential diagnosis of disorders of water metabolism.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“A strong correlation between plasma AVP (when measured with a well-established radio-immunoassay) and copeptin levels has been demonstrated in healthy volunteers (184), and, therefore, copeptin measurement could be an alternative marker to elucidate the effects of opioids on AVP.”
From Exogenous Opioids and the Human Endocrine System: An Endocrine Society Scientific Statement (2024) · cites this paper as [184]
Citations
Cites
Assay for the Measurement of Copeptin, a Stable Peptide Derived from the Precursor of Vasopressin
Morgenthaler, N. G., Struck, J., Alonso, C., & Bergmann, A. (2006) · Clinical Chemistry · doi:10.1373/clinchem.2005.060038 · Cited by 1,166 · cited 5×
“A sensitive sandwich immunoassay for the detection of copeptin in human serum or plasma has recently been developed (8), offering a potential alternative to available AVP assays.”
BackgroundMethodSelf-citationRobertson, G. L., Mahr, E. A., Athar, S., & Sinha, T. (1973) · Journal of Clinical Investigation · doi:10.1172/jci107423 · Cited by 787 · cited 6×
“Kluge M, Riedl S, Erhart-Hofmann B, Hartmann J, Waldhauser F 1999 Improved extraction procedure and RIA for determination of arginine8-vasopressin in plasma: role of premeasurement sample treatment and reference values in children.”
BackgroundMethodInfluentialNucleotide sequence of cloned cDNA encoding bovine arginine vasopressin-neurophysin II precursor
Land, H., Schütz, G., Schmale, H., & Richter, D. (1982) · Nature · doi:10.1038/295299a0 · Cited by 569 · cited 1×
“AVP is synthesized as prepro-hormone and consists of a signal peptide, the AVP and neurophysin II moieties, and a C-terminal peptide of 39 amino acids, termed copeptin, that contains a single N-linked glycosylation site (5, 6) (Fig.”
BackgroundOsmotic and nonosmotic control of vasopressin release
Schrier, R. W., Berl, T., & Anderson, R. J. (1979) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.1979.236.4.f321 · Cited by 502 · cited 1×
“circulating blood volume and low blood pressure (3), as”
BackgroundIncremental Value of Copeptin for Rapid Rule Out of Acute Myocardial Infarction
Reichlin, T., Hochholzer, W., Stelzig, C., Laule, K., Freidank, H., Morgenthaler, N. G., Bergmann, A., Potocki, M., Noveanu, M., Breidthardt, T., et al. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.01.076 · Cited by 434
Self-citationCopeptin: clinical use of a new biomarker
Morgenthaler, N. G., Struck, J., Jochberger, S., & Dünser, M. W. (2008) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2007.11.001 · Cited by 408
Self-citationKhan, S. Q., Dhillon, O. S., O’Brien, R. J., Struck, J., Quinn, P. A., Morgenthaler, N. G., Squire, I. B., Davies, J. E., Bergmann, A., & Ng, L. L. (2007) · Circulation · doi:10.1161/circulationaha.106.685503 · Cited by 353
Self-citationSausville, E., Carney, D., & Battey, J. (1985) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)39236-0 · Cited by 338
Copeptin Improves Early Diagnosis of Acute Myocardial Infarction
Keller, T., Tzikas, S., Zeller, T., Czyz, E., Lillpopp, L., Ojeda, F. M., Roth, A., Bickel, C., Baldus, S., Sinning, C. R., et al. (2010) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2010.01.029 · Cited by 336 · cited 1×
“9 pM found in a large reference population (31).”
BackgroundCopeptin and Arginine Vasopressin Concentrations in Critically Ill Patients
Jochberger, S., Morgenthaler, N. G., Mayr, V. D., Luckner, G., Wenzel, V., Ulmer, H., Schwarz, S., Hasibeder, W. R., Friesenecker, B. E., & Dünser, M. W. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-2830 · Cited by 271 · cited 2×
“Hence, the clearance may be impaired in renal disease (16).”
BackgroundSelf-citation
Cited by
Disorders of Plasma Sodium — Causes, Consequences, and Correction
Sterns, R. H. (2015) · New England Journal of Medicine · doi:10.1056/nejmra1404489 · Cited by 634
A Copeptin-Based Approach in the Diagnosis of Diabetes Insipidus
Fenske, W., Refardt, J., Chifu, I., Schnyder, I., Winzeler, B., Drummond, J., Ribeiro-Oliveira, A., Drescher, T., Bilz, S., Vogt, D. R., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1803760 · Cited by 310
Vasopressin: physiology, assessment and osmosensation
Bankir, L., Bichet, D. G., & Morgenthaler, N. G. (2017) · Journal of Internal Medicine · doi:10.1111/joim.12645 · Cited by 266
Self-citationMeasuring Oxytocin and Vasopressin: Bioassays, Immunoassays and Random Numbers
Leng, G., & Sabatier, N. (2016) · Journal of Neuroendocrinology · doi:10.1111/jne.12413 · Cited by 237
Water Intake, Water Balance, and the Elusive Daily Water Requirement
Armstrong, L. E., & Johnson, E. C. (2018) · Nutrients · doi:10.3390/nu10121928 · Cited by 235
Current State and Future Perspectives in the Diagnosis of Diabetes Insipidus: A Clinical Review
Fenske, W., & Allolio, B. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-1981 · Cited by 220
“Within the last few years, copeptin, the C-terminal glycoprotein of the AVP prohormone, has been established as an easy to measure and stable surrogate for endogenous plasma AVP (91, 93, 94).”
BackgroundTimper, K., Fenske, W., Kühn, F., Frech, N., Arici, B., Rutishauser, J., Kopp, P., Allolio, B., Stettler, C., Müller, B., et al. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-4507 · Cited by 201
“By contrast, copeptin, which is cosecreted stoichiometrically with AVP (11, 12, 19), is more stable, and can be easily measured in serum or plasma (6, 15).”
BackgroundSelf-citationCopeptin in the diagnosis of vasopressin-dependent disorders of fluid homeostasis
Christ-Crain, M., & Fenske, W. (2016) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2015.224 · Cited by 189
Diagnosis and Management of Central Diabetes Insipidus in Adults
Tomkins, M., Lawless, S., Martin-Grace, J., Sherlock, M., & Thompson, C. J. (2022) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgac381 · Cited by 159
Winzeler, B. F., Cesana-Nigro, N., Refardt, J. C., Vogt, D., Imber, C., Morin, B., Popovic, M., Steinmetz, M., Sailer, C. O., Szinnai, G., et al. (2019) · The Lancet · doi:10.1016/s0140-6736(19)31255-3 · Cited by 182
Copeptin and its potential role in diagnosis and prognosis of various diseases
Dobsa, L., & Edozien, K. C. (2013) · Biochemia Medica · doi:10.11613/bm.2013.021 · Cited by 168
“It is assumed that it is partially cleared through the kidneys because it is detectable in urine (7).”
BackgroundMethodInfluentialChapman, C. L., Johnson, B. D., Vargas, N. T., Hostler, D., Parker, M. D., & Schlader, Z. J. (2020) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00787.2019 · Cited by 145
Roussel, R., Fezeu, L., Marre, M., Velho, G., Fumeron, F., Jungers, P., Lantieri, O., Balkau, B., Bouby, N., Bankir, L., et al. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-2295 · Cited by 141
Diagnosis and management of central diabetes insipidus in adults
Garrahy, A., Moran, C., & Thompson, C. J. (2018) · Clinical Endocrinology · doi:10.1111/cen.13866 · Cited by 149
Vasopressin and Copeptin in health and disease
Christ‐Crain, M. (2019) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-019-09509-9 · Cited by 136
“Using the well-established AVP assay from Gary Robertson, Chiacago [2] a direct comparison between copeptin and AVP release in relationship to serum osmolality showed a very strong correlation between both peptides (r = 0.8) and a stronger correlation for serum osmolality with copeptin (r = 0.77) than with AVP (r = 0.…”
BackgroundMethodInfluentialCopeptin (CTproAVP), a new tool for understanding the role of vasopressin in pathophysiology
Bolignano, D., Cabassi, A., Fiaccadori, E., Ghigo, E., Pasquali, R., Peracino, A., Peri, A., Plebani, M., Santoro, A., Settanni, F., et al. (2014) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2014-0379 · Cited by 123
“The measurement of CTproAVP can be used to reflect AVP concentrations as it is produced in equimolar amounts as AVP and released into the circulation at the same time as AVP secretion [15].”
Refardt, J. C., Winzeler, B. F., & Christ‐Crain, M. (2019) · Clinical Endocrinology · doi:10.1111/cen.13991 · Cited by 142
Diagnosis and management of diabetes insipidus for the internist: an update
Christ‐Crain, M., Winzeler, B. F., & Refardt, J. C. (2021) · Journal of Internal Medicine · doi:10.1111/joim.13261 · Cited by 158
Erythropoiesis with endurance training: dynamics and mechanisms
Montero, D., Breenfeldt-Andersen, A., Oberholzer, L., Haider, T., Goetze, J. P., Meinild-Lundby, A.-K., & Lundby, C. (2017) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00012.2017 · Cited by 116
Fenske, W. K., Schnyder, I., Koch, G., Walti, C. S., Pfister, M., Kopp, P. A., Faßnacht, M., Strauss, K., & Christ‐Crain, M. (2017) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2017-01891 · Cited by 124
“Similar patterns of copeptin release or behavior, respectively, and mature AVP could be confirmed in various trials both in health (1, 10, 11) and disease (8, 12–15).”
BackgroundSelf-citationSex Differences in the Effects of MDMA (Ecstasy) on Plasma Copeptin in Healthy Subjects
Simmler, L. D., Hysek, C. M., & Liechti, M. E. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-1143 · Cited by 90
Plasma Copeptin and Renal Outcomes in Patients With Type 2 Diabetes and Albuminuria
Velho, G., Bouby, N., Hadjadj, S., Matallah, N., Mohammedi, K., Fumeron, F., Potier, L., Bellili-Munoz, N., Taveau, C., Alhenc-Gelas, F., et al. (2013) · Diabetes Care · doi:10.2337/dc13-0683 · Cited by 89
“Studies in healthy subjects have shown plasma copeptin and vasopressin concentrations to correlate strongly over a wide range of osmolalities (5,6).”
BackgroundFenske, W. K., Christ‐Crain, M., Hörning, A., Simet, J., Szinnai, G., Faßnacht, M., Rutishauser, J., Bichet, D. G., Störk, S., & Allolio, B. (2014) · Journal of the American Society of Nephrology · doi:10.1681/asn.2013080895 · Cited by 93
Self-citationPostoperative Copeptin Concentration Predicts Diabetes Insipidus After Pituitary Surgery
Winzeler, B., Zweifel, C., Nigro, N., Arici, B., Bally, M., Schuetz, P., Blum, C. A., Kelly, C., Berkmann, S., Huber, A., et al. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-4527 · Cited by 83
“09 Tumor characteristics Largest diameter, mm 24 [18–29] 19 [14–25] .”
Gansevoort, R. T., van Gastel, M. D. A., Chapman, A. B., Blais, J. D., Czerwiec, F. S., Higashihara, E., Lee, J., Ouyang, J., Perrone, R. D., Stade, K., et al. (2019) · Kidney International · doi:10.1016/j.kint.2018.11.044 · Cited by 85
“Copeptin levels correlate with vasopressin levels during physiological changes in plasma osmolality, from water excess to dehydration.(18,19) Measurement of copeptin is increasingly preferred over measurement of vasopressin in clinical and epidemiological studies as well as in clinical routine, because of the technica…”
BackgroundPlasma Copeptin, AVP Gene Variants, and Incidence of Type 2 Diabetes in a Cohort From the Community
Roussel, R., Boustany, R. E., Bouby, N., Potier, L., Fumeron, F., Mohammedi, K., Balkau, B., Tichet, J., Bankir, L., Marre, M., et al. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-1113 · Cited by 78
Copeptin as a Diagnostic and Prognostic Biomarker in Cardiovascular Diseases
Mu, D., Cheng, J. H., Qiu, L., & Cheng, X. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.901990 · Cited by 81
“The release of copeptin is regulated by osmotic pressure changes (38, 39).”
BackgroundCopeptin concentrations during psychological stress: the PsyCo study
Siegenthaler, J., Walti, C., Urwyler, S. A., Schuetz, P., & Christ-Crain, M. (2014) · European Journal of Endocrinology · doi:10.1530/eje-14-0405 · Cited by 66
Hannon, M. J., & Verbalis, J. G. (2014) · Current Opinion in Nephrology & Hypertension · doi:10.1097/01.mnh.0000447022.51722.f4 · Cited by 72
Enhörning, S., Tasevska, I., Roussel, R., Bouby, N., Persson, M., Burri, P., Bankir, L., & Melander, O. (2017) · European Journal of Nutrition · doi:10.1007/s00394-017-1595-8 · Cited by 74
“0 pmol/L within 120 min after an acute water load (20 mL/kg body weight) in young healthy subjects [9].”
BackgroundAmro, O. W., Paulus, J. K., Noubary, F., & Perrone, R. D. (2016) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2016.07.023 · Cited by 64
“Copeptin is a reliable marker of AVP secretion (15, 16), furthermore, plasma vasopressin and copeptin solidly correlate across a span of osmolalities and circulating copeptin levels, reflecting the antidiuretic effect of vasopressin at the level of the target organ(17).”
BackgroundEnhörning, S., Brunkwall, L., Tasevska, I., Ericson, U., Tholin, J. P., Persson, M., Lemetais, G., Vanhaecke, T., Dolci, A., Perrier, E. T., et al. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-02195 · Cited by 72
Velho, G., Boustany, R. E., Lefèvre, G., Mohammedi, K., Fumeron, F., Potier, L., Bankir, L., Bouby, N., Hadjadj, S., Marre, M., et al. (2016) · Diabetes Care · doi:10.2337/dc16-1003 · Cited by 67
“Circulating levels of vasopressin and copeptin correlate over a wide range of plasma osmolality (7,8), and copeptin,”
BackgroundPonte, B., Pruijm, M. T., Ackermann, D., Vuistiner, P., Guessous, I., Ehret, G., Alwan, H., Youhanna, S. C., Paccaud, F., Mohaupt, M. G., et al. (2014) · Journal of the American Society of Nephrology · doi:10.1681/asn.2014030260 · Cited by 61
Gul, S. S., Huesgen, K. W., Wang, K., Mark, K., & Tyndall, J. A. (2017) · Medical Hypotheses · doi:10.1016/j.mehy.2017.06.016 · Cited by 59
“predictive at hr 12) 24 mins [141] Similar to vasopressin’s (AVP) half-life,”
BackgroundLong-term health outcomes associated with hydration status
Dmitrieva, N. I., Boehm, M., Yancey, P. H., & Enhörning, S. (2024) · Nature Reviews Nephrology · doi:10.1038/s41581-024-00817-1 · Cited by 71
“…plasma sodium, AVP (or its surrogate measure copeptin) and renin activity, and is accompanied by decreased urine volume and increased urine osmolality, urine gravity and a more intense urine colour, all of which have been proposed as biomarkers of acute underhydration 40–42 ,81, 89, 90 ( Fig.”
Christ‐Crain, M., & Gaisl, O. (2021) · La Presse Médicale · doi:10.1016/j.lpm.2021.104093 · Cited by 75
Approach to the Patient: “Utility of the Copeptin Assay”
Christ‐Crain, M., Refardt, J. C., & Winzeler, B. F. (2022) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgac070 · Cited by 66
Vasopressin–aquaporin-2 pathway: recent advances in understanding water balance disorders
Ranieri, M., Mise, A. D., Tamma, G., & Valenti, G. (2019) · F1000Research · doi:10.12688/f1000research.16654.1 · Cited by 57
“Indeed, it has been reported that plasma concentrations of copeptin correlate strongly in several clinical conditions 32,33,35,36 .”
BackgroundSailer, C. O., Refardt, J. C., Blum, C. A., Schnyder, I., Molina‐Tijeras, J. A., Fenske, W. K., & Christ‐Crain, M. (2021) · Scientific Reports · doi:10.1038/s41598-021-89505-9 · Cited by 63
Copeptin in heart failure: Review and meta-analysis
Yao, Z., Wang, R., Yan, L., Lin, M., Liu, X., & You, T. (2017) · Clinica Chimica Acta · doi:10.1016/j.cca.2017.10.001 · Cited by 61
Roussel, R., Matallah, N., Bouby, N., Boustany, R. E., Potier, L., Fumeron, F., Mohammedi, K., Balkau, B., Marre, M., Bankir, L., et al. (2015) · American Journal of Nephrology · doi:10.1159/000439061 · Cited by 57
Plasma copeptin as biomarker of disease progression and prognosis in cirrhosis
Solà, E., Kerbert, A. J. C., Verspaget, H. W., Moreira, R., Pose, E., Ruíz, P., Cela, R., Morales‐Ruiz, M., López, E., Graupera, I., et al. (2016) · Journal of Hepatology · doi:10.1016/j.jhep.2016.07.003 · Cited by 53
Tuli, G., Tessaris, D., Einaudi, S., Matarazzo, P., & SANCTIS, L. D. (2018) · Clinical Endocrinology · doi:10.1111/cen.13583 · Cited by 49
Diagnosis and differential diagnosis of diabetes insipidus: Update
Refardt, J. C. (2020) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2020.101398 · Cited by 58
Plasma copeptin and chronic kidney disease risk in 3 European cohorts from the general population
Boustany, R. E., Tasevska, I., Meijer, E., Kieneker, L. M., Enhörning, S., Lefèvre, G., Mohammedi, K., Marre, M., Fumeron, F., Balkau, B., et al. (2018) · JCI Insight · doi:10.1172/jci.insight.121479 · Cited by 51
Hyponatremia and anti-diuretic hormone in Legionnaires’ disease
Schüetz, P., Haubitz, S., Christ‐Crain, M., Albrich, W. C., Zimmerli, W., Müeller, B., & the ProHOSP Study Group (2013) · BMC Infectious Diseases · doi:10.1186/1471-2334-13-585 · Cited by 48
Montero, D., Rauber, S., Goetze, J. P., & Lundby, C. (2016) · Acta Physiologica · doi:10.1111/apha.12708 · Cited by 44
“Given the strong correlation between copeptin and VPN, copeptin is commonly used as a marker for VPN in clinical and research settings (Khan et al. 2007, Morgenthaler et al. 2008, Balanescu et al. 2011, Roussel et al. 2014).”
MethodNephrogenic diabetes insipidus: a comprehensive overview
de Castro, P. A. S. V., Bitencourt, L., Campos, J. L. D. O., Fischer, B. L., de Brito, S. B. C. S., Soares, B. S., Drummond, J., & Silva, A. C. S. E. (2022) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem-2021-0566 · Cited by 50
Conrad, K. P. (2016) · Human Reproduction Update · doi:10.1093/humupd/dmw021 · Cited by 48
“Indeed, many investigators have successfully measured AVP in nonpregnant subjects (Robertson et al., 1973; Balanescu et al., 2011; ElFarhan et al., 2013), and by taking appropriate steps to inactivate vasopressinase, AVP measurements in pregnancy have also been reliable (Davison et al.”
BackgroundArginine vasopressin deficiency: diagnosis, management and the relevance of oxytocin deficiency
Atila, C., Refardt, J. C., & Christ‐Crain, M. (2024) · Nature Reviews Endocrinology · doi:10.1038/s41574-024-00985-x · Cited by 60
“Owing to their shared neurosecretory granule storage, copeptin and AVP are co-secreted in response to increases in plasma osmo-lality or volume depletion, and the secretion of both factors is suppressed in response to fluid intake 36,38,39 .”
BackgroundMethodManagement of Diabetes Insipidus following Surgery for Pituitary and Suprasellar Tumors
Almalki, M., Ahmad, M. M., Brema, I. A., Almehthel, M. S., Aldahmani, K. M., Mahzari, M. M., & Beshyah, S. (2021) · Sultan Qaboos University medical journal · doi:10.18295/squmj.4.2021.010 · Cited by 51
“Unlike AVP, copeptin measurement is less cumbersome as it remains stable in collected plasma samples for days and its measurement is associated with less preanalytical errors.(50,51) Copeptin is highly accurate in identifying the etiology of polyuria in the non-acute setting.”
BackgroundAngelousi, A. G., Alexandraki, K., Mytareli, C., Grossman, A. B., & Kaltsas, G. (2023) · Journal of Neuroendocrinology · doi:10.1111/jne.13233 · Cited by 55
“Copeptin (C-terminal peptide of pro-vasopressin) is co-secreted with AVP and is more stable.(136,137) Initial data suggested that baseline copeptin levels < 2.”
BackgroundFlahault, A., Couvineau, P., Alvear‐Perez, R., Iturrioz, X., & Llorens‐Cortés, C. (2017) · Frontiers in Endocrinology · doi:10.3389/fendo.2017.00120 · Cited by 44
“Copeptin is released mole to mole with AVP from the posterior pituitary in the blood circulation and plasma copeptin levels are used as a surrogate marker for AVP release in humans (95, 96).”
MethodDiabetes Insipidus: New Concepts for Diagnosis
Christ‐Crain, M. (2020) · Neuroendocrinology · doi:10.1159/000505548 · Cited by 52
Sandgren, J. A., Linggonegoro, D. W., Zhang, S. Y., Sapouckey, S. A., Claflin, K. E., Pearson, N. A., Leidinger, M., Pierce, G. L., Santillan, M. K., Gibson-Corley, K. N., et al. (2018) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00435.2017 · Cited by 49
Enhörning, S., & Melander, O. (2018) · Annals of Nutrition and Metabolism · doi:10.1159/000488304 · Cited by 40
Negri, A. L., & Ayus, J. C. (2016) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-016-9387-7 · Cited by 40
“Recent studies have demonstrated that copeptin, the C-terminal glycoprotein of the AVP prohormone, is a stable surrogate for endogenous AVP secretion, which is easier to measure [50, 51] and may, thus, allowmore accurate determination of the relationship between AVP and BMD in future studies.”
BackgroundChapman, C. L., Grigoryan, T., Vargas, N. T., Reed, E. L., Kueck, P. J., Pietrafesa, L. D., Bloomfield, A. C., Johnson, B. D., & Schlader, Z. J. (2020) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00374.2019 · Cited by 43
“Fructose in serum and urine was measured using a commercially available fructose ELISA kit (LifeSpan BioSciences, Seattle, WA).”
MethodInfluentialJalleh, R. J., & Torpy, D. J. (2021) · Clinical Biochemist Reviews · doi:10.33176/aacb-20-00001 · Cited by 45
Christ‐Crain, M., Morgenthaler, N. G., & Fenske, W. K. (2016) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2016.02.003 · Cited by 35
Self-citationAssociation of HPA axis hormones with copeptin after psychological stress differs by sex
Spanakis, E. K., Wand, G. S., Ji, N., & Golden, S. H. (2015) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2015.10.009 · Cited by 38
“Changes in plasma osmolality and in sodium levels can cause alternations in copeptin levels (Balanescu et al., 2011).”
BackgroundGenetic forms of neurohypophyseal diabetes insipidus
Rutishauser, J., Spiess, M., & Kopp, P. A. (2016) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2016.02.008 · Cited by 38
Self-citationSeery, S., & Jakeman, P. M. (2016) · British Journal Of Nutrition · doi:10.1017/s0007114516002907 · Cited by 38
“sensitive to measurement by specific immunoassay and representative of the antidiuretic effect of AVP((27)).”
InfluentialBonnet, L., Marquant, E., Fromonot, J., Hamouda, I., Berbis, J., Godefroy, A., Vierge, M., Tsimaratos, M., & Reynaud, R. (2021) · Clinical Endocrinology · doi:10.1111/cen.14620 · Cited by 37
“Chemiluminescence or immunofluorescence assays yield results in just a few hours on very small (50 μl) blood samples, with a detection threshold low enough to allow the analysis of diluted serum.(5,6) Copeptin measurements have been used for several years for various indications, notably in adults as a predictive mark…”
BackgroundDisorders of Salt and Water Balance After Pituitary Surgery
Brooks, E., & Inder, W. J. (2022) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgac622 · Cited by 36
Distribution of plasma copeptin levels and influence of obesity in children and adolescents
Tuli, G., Munarin, J., Tessaris, D., Einaudi, S., Matarazzo, P., & SANCTIS, L. D. (2020) · European Journal of Pediatrics · doi:10.1007/s00431-020-03777-3 · Cited by 33
Castle‐Kirszbaum, M., Fuller, P. J., Wang, Y. Y., King, J. A. J., & Goldschlager, T. (2021) · Pituitary · doi:10.1007/s11102-021-01159-y · Cited by 37
“Copeptin is cleaved from the precursor protein pre-pro-vasopressin together with AVP and neurophysin II, and thus copeptin levels correlate well with AVP [38].”
BackgroundComparison of ex vivo stability of copeptin and vasopressin
Heida, J. E., Boesten, L. S. M., Ettema, E. M., Kobold, A. C. M., Franssen, C. F. M., Gansevoort, R. T., & Zittema, D. (2016) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2016-0559 · Cited by 38
The Effect of Renal Function and Hemodialysis Treatment on Plasma Vasopressin and Copeptin Levels
Ettema, E. M., Heida, J. E., Casteleijn, N. F., Boesten, L. S. M., Westerhuis, R., Gaillard, S., Gansevoort, R. T., Franssen, C. F. M., & Zittema, D. (2017) · Kidney International Reports · doi:10.1016/j.ekir.2017.01.006 · Cited by 35
“Partial renal clearance of copeptin has been suggested before, as copeptin has been found in urine.(7) Renal clearance, however, will presumably not be the predominant factor in the degradation of copeptin because a fast decrease in copeptin levels has been observed within minutes after the start of water loading(5,7)…”
Diabetes Insipidus and Syndrome of Inappropriate Antidiuretic Hormone in Critically Ill Patients
Harrois, A., & Anstey, J. R. (2019) · Critical Care Clinics · doi:10.1016/j.ccc.2018.11.001 · Cited by 34
Yadav, S., Yadav, J., Kumar, S., & Singh, P. K. (2024) · Springer eBooks · doi:10.1007/978-981-97-4723-8_8 · Cited by 38
New insights on diagnosis and treatment of AVP deficiency
Refardt, J. C., Atila, C., & Christ‐Crain, M. (2023) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-023-09862-w · Cited by 35
“A direct comparison between copeptin and AVP release in relationship to serum osmolality using the well-established AVP assay showed a stronger correlation for serum osmolality with copeptin than with AVP and a very strong correlation between both peptides [ 23 ].”
ResultCopeptin: a new marker in cardiology
Morawiec, B., & Kawecki, D. (2012) · Journal of Cardiovascular Medicine · doi:10.2459/jcm.0b013e3283590d59 · Cited by 30
Copeptin in fluid disorders and stress
Mu, D., Ma, C., Cheng, J. H., Zou, Y., Qiu, L., & Cheng, X. (2022) · Clinica Chimica Acta · doi:10.1016/j.cca.2022.02.002 · Cited by 32
Copeptin during rest and exercise in major depression
Krogh, J., Goetze, J. P., Jørgensen, M. B., Kristensen, L. Ø., Kistorp, C., & Nordentoft, M. (2013) · Journal of Affective Disorders · doi:10.1016/j.jad.2013.06.007 · Cited by 29
“8 between copeptin and vasopressin in healthy volunteers during different states of osmolality, which was supported by a high correlation between copeptin and osmolality (Balanescu et al., 2011).”
BackgroundHoffiz, Y. C., Castillo‐Ruiz, A., Hall, M. A. L., Hite, T. A., Gray, J. M., Cisternas, C. D., Cortes, L. R., Jacobs, A. J., & Forger, N. G. (2021) · Scientific Reports · doi:10.1038/s41598-021-81511-1 · Cited by 28
Kerbert, A. J. C., Verspaget, H. W., Navarro, À. A., Jalan, R., Solà, E., Benten, D., Durand, F., Ginès, P., van der Reijden, J. J., van Hoek, B., et al. (2017) · Critical Care · doi:10.1186/s13054-017-1894-8 · Cited by 33
“Copeptin is a stable cleavage product of the C-terminal part of the AVP precursor and is secreted together with AVP in equimolar amounts [9, 10].”
BackgroundNeuroendocrine adaptations to starvation
Amorim, T., Khiyami, A. M., Latif, T., & Fazeli, P. K. (2023) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2023.106365 · Cited by 36
Balling, L., & Gustafsson, F. (2016) · Advances in clinical chemistry · doi:10.1016/bs.acc.2015.10.006 · Cited by 26
Vasopressin and diabetic nephropathy
Roussel, R., Velho, G., & Bankir, L. (2017) · Current Opinion in Nephrology & Hypertension · doi:10.1097/mnh.0000000000000335 · Cited by 27
EJE AWARD 2019: New diagnostic approaches for patients with polyuria polydipsia syndrome
Christ‐Crain, M. (2019) · European Journal of Endocrinology · doi:10.1530/eje-19-0163 · Cited by 31
Walti, C. S., Siegenthaler, J., & Christ‐Crain, M. (2014) · Biomarkers · doi:10.3109/1354750x.2014.940504 · Cited by 23
“Both are produced in the hypothalamus, stored in the posterior pituitary gland, and secreted upon several stimuli, primarily hyperosmolality, but also hypotension or generalized stress (Balanescu et al., 2011; Morgenthaler et al., 2006; Szinnai et al., 2007).”
BackgroundResultInfluentialCopeptin: Up-to-date diagnostic and prognostic role highlight
Abdelmageed, M., & Güzelgül, F. (2023) · Analytical Biochemistry · doi:10.1016/j.ab.2023.115181 · Cited by 28
Fenske, W. K., Sandner, B., & Christ‐Crain, M. (2016) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2016.02.013 · Cited by 26
Ettema, E. M., Kuipers, J., Assa, S., Bakker, S. J. L., Groen, H., Westerhuis, R., Gaillard, S., Gansevoort, R. T., & Franssen, C. F. M. (2015) · PLoS ONE · doi:10.1371/journal.pone.0127116 · Cited by 23
Effects of atosiban on stress-related neuroendocrine factors
Babic, S., Pokusa, M., Danevova, V., Ding, S., & Ježová, D. (2015) · Journal of Endocrinology · doi:10.1530/joe-14-0560 · Cited by 23
Takagi, H., Hagiwara, D., Handa, T., Sugiyama, M., Onoue, T., Tsunekawa, T., Ito, Y., Iwama, S., Goto, M., Suga, H., et al. (2019) · Endocrine Journal · doi:10.1507/endocrj.ej19-0224 · Cited by 22
Satoh, K., Oti, T., Katoh, A., Ueta, Y., Morris, J. F., Sakamoto, T., & Sakamoto, H. (2015) · FEBS Journal · doi:10.1111/febs.13291 · Cited by 21
Copeptin as an Indicator of Hemodynamic Derangement and Prognosis in Liver Cirrhosis
Kerbert, A. J. C., Verbeke, L., Chiang, F. W. T., Laleman, W., van der Reijden, J. J., van Duijn, W., Nevens, F., Wolterbeek, R., van Hoek, B., Verspaget, H. W., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0138264 · Cited by 21
“Moreover, copeptin is secreted together with AVP in equimolar amounts and has a strong correlation with AVP over a wide range of osmolalities [12, 13].”
BackgroundRemde, H., Dietz, A., Emeny, R. T., Riester, A., Peters, A., Gala, T. D. L. H., Then, C., Seißler, J., Beuschlein, F., Reincke, M., et al. (2016) · Journal of Hypertension · doi:10.1097/hjh.0000000000001041 · Cited by 23
“Copeptin and AVP are secreted from the posterior pituitary in equimolar amounts; therefore, copeptin levels reliably reflect activation of the AVP system [8].”
Fernandez, S. J., Barakat, I., Ziogas, J., Frugier, T., Stylli, S. S., Laidlaw, J. D., Kaye, A. H., & Adamides, A. A. (2018) · Journal of neurosurgery · doi:10.3171/2017.10.jns17795 · Cited by 21
Copeptin in the differential diagnosis of hypotonic polyuria
Christ‐Crain, M., & Fenske, W. K. (2019) · Journal of Endocrinological Investigation · doi:10.1007/s40618-019-01087-6 · Cited by 22
Francisco, R., Jesus, F., Nunes, C. L., Cioffi, I., Alvim, M., Mendonca, G. V., Lukaski, H., Sardinha, L. B., & Silva, A. M. (2023) · Scandinavian Journal of Medicine & Science in Sports · doi:10.1111/sms.14355 · Cited by 20
Water intake keeps type 2 diabetes away? Focus on copeptin
Muscogiuri, G., Barrea, L., Annunziata, G., Vecchiarini, M., Orio, F., Somma, C. D., Colao, A., & Savastano, S. (2018) · Endocrine · doi:10.1007/s12020-018-1680-7 · Cited by 20
Serum copeptin in children exposed to maltreatment
Coelho, R. P. S., Levandowski, M. L., Mansur, R. B., da Cunha, G. R., Asevedo, E. D. M., Zugman, A., Salum, G. A., Gadelha, A., Pan, P. M., Rizzo, L. B., et al. (2016) · Psychiatry and Clinical Neurosciences · doi:10.1111/pcn.12412 · Cited by 21
“Copeptin is released in equimolar amounts with AVP in the circulation of healthy and critically ill subjects.(22,23) In addition, copeptin is more stable in the circulation; blood levels have no consistent circadian rhythm and they are easy to determine.”
BackgroundThe vasopressin system: new insights for patients with kidney diseases
Clark, W. F., Devuyst, O., & Roussel, R. (2017) · Journal of Internal Medicine · doi:10.1111/joim.12654 · Cited by 30
Urine Electrolytes in the Intensive Care Unit: From Pathophysiology to Clinical Practice
Umbrello, M., Formenti, P., & Chiumello, D. (2020) · Anesthesia & Analgesia · doi:10.1213/ane.0000000000004994 · Cited by 20
Effects of sex and menstrual cycle on volume-regulatory responses to 24-h fluid restriction
Giersch, G. E. W., Colburn, A. T., Morrissey, M. C., Butler, C. R., Pruchnicki, M. L., Kavouras, S. A., Charkoudian, N., & Casa, D. J. (2020) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00173.2020 · Cited by 27
Hu, H., Zarate, C. A., & Verbalis, J. G. (2024) · Psychiatry and Clinical Neurosciences · doi:10.1111/pcn.13703 · Cited by 20
“112 Future psychiatric biomarker studies investigating copeptin can account for physiological factors that may confound the measurements, such as states of dehydration, sodium levels and/or salt intake, use of diuretic medications, and any other medical comorbidities that may in fl uence the…”
Metadata
- Authors
- Balanescu, S., Kopp, P., Gaskill, M. B., Morgenthaler, N. G., Schindler, C., & Rutishauser, J.
- Affiliations
- Spitalzentrum Centre hospitalier Biel- Bienne (CH)
- Northwestern University (US)
- Thermo Fisher Scientific (Germany) (DE)
- University of Basel (CH)
- Corresponding author
- Rutishauser, Jonas
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2011-04-01
- Volume
- 96
- Issue
- 4
- Pages
- 1046-1052
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W1991337124
- Semantic Scholar
- 844c5958060267f48000cd5026591990d577e9c1
- Cited by
- 246
- References
- 33
- Citations by year
- 2026: 7 · 2025: 11 · 2024: 22 · 2023: 23 · 2022: 19 · 2021: 23 · 2020: 23 · 2019: 16 · 2018: 19 · 2017: 19 · 2016: 26 · 2015: 12 · 2014: 13 · 2013: 9 · 2012: 3
- FWCI
- 7.06
- Type
- journal article
- Language
- en
- Open access
- green
- doi.org
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- edoc (University of Basel) (acceptedVersion)
- edoc (University of Basel)
- Topics
- Health Sciences › Medicine › Nephrology › Electrolyte and hormonal disorders
- Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Neuroendocrine regulation and behavior
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuropeptides and Animal Physiology
- Keywords
- copeptin, vasopressin, plasma osmolality, water homeostasis, hypoosmolarity, hyperosmolarity, water load, hypertonic saline infusion
- MeSH terms
- Adult, Female, Glycopeptides, Health Status, Humans, Hypotonic Solutions, Male, Osmolar Concentration, Saline Solution, Hypertonic, Vasopressins, Water, Water-Electrolyte Balance, Water-Electrolyte Imbalance, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.